News | August 25, 2025
J&J to invest $2 billion at CDMO Fujifilm’s new hub
Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the U.S. to meet the needs of patients in the U.S.
Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the U.S. to meet the needs of patients in the U.S.
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
Distribution agreement enables FUJIFILM India to offer Spectra Logic advanced tape libraries and software solutions to enterprise customers and channel partners
The system is powered by advanced imaging innovations such as Amber-red Color Imaging, Triple Noise Reduction, and Extended Dynamic Range Image Processing
The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
The EBUS is designed to support the diagnosis and staging of various lung disorders
Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians
Fujifilm has been at the forefront of medical imaging and healthcare informatics. It’s developing new AI platforms to address medical challenges. Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India gives us an insight in an interview with Thomas C. Thottathil, Editor, indianpharmapost.com
The enhanced portfolio includes the Scenaria View, Supria series, The Echelon Smart and Arietta series
Fujifilm India will be providing healthcare Imaging devices and equipment’s to increase the standards of the veterinary care in India.
Subscribe To Our Newsletter & Stay Updated
